Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) was up 47.4% during mid-day trading on Friday . The stock traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares changed hands during trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The company’s fifty day simple moving average is C$0.07 and its two-hundred day simple moving average is C$0.06. The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The stock has a market capitalization of C$19.53 million, a P/E ratio of -14.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- What is the NASDAQ Stock Exchange?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- High Flyers: 3 Natural Gas Stocks for March 2022
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
